{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:55:29Z","timestamp":1763830529595,"version":"build-2065373602"},"reference-count":51,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T00:00:00Z","timestamp":1353974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sensors"],"abstract":"<jats:p>Great interest is currently being devoted to the development of nanoparticles (NPs) for biomedical purposes, designed to improve the pharmacokinetic profile of their cargos (either imaging probes or drugs) and to enhance the specific targeting at the disease site. Recent works suggest that Surface Plasmon Resonance (SPR), widely used for the analysis of biomolecular interactions, represents a technique of choice for rapid and quantitative analyses of the interaction between NPs\u2014functionalized with specific ligands\u2014and their putative biological targets. Moreover, SPR can provide important details on the formation and the role of the protein \u201ccorona\u201d, i.e., the protein layer which coats NPs once they come into contact with biological fluids. These novel applications of SPR sensors may be very useful to characterize, screen and develop nanodevices for biomedical purposes.<\/jats:p>","DOI":"10.3390\/s121216420","type":"journal-article","created":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T11:14:30Z","timestamp":1354014870000},"page":"16420-16432","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Applications of Surface Plasmon Resonance (SPR) for the Characterization of Nanoparticles Developed for Biomedical Purposes"],"prefix":"10.3390","volume":"12","author":[{"given":"Mara","family":"Canovi","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Pharmacology, Mario Negri Institute for Pharmacological Research, Milano 20156, Italy"}]},{"given":"Jacopo","family":"Lucchetti","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Pharmacology, Mario Negri Institute for Pharmacological Research, Milano 20156, Italy"}]},{"given":"Matteo","family":"Stravalaci","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Pharmacology, Mario Negri Institute for Pharmacological Research, Milano 20156, Italy"}]},{"given":"Francesca","family":"Re","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Milano Bicocca, Monza 20052, Italy"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2759-9781","authenticated-orcid":false,"given":"Davide","family":"Moscatelli","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Materials and Chemical Engineering, Politecnico di Milano, Milano 20131, Italy"}]},{"given":"Paolo","family":"Bigini","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Pharmacology, Mario Negri Institute for Pharmacological Research, Milano 20156, Italy"}]},{"given":"Mario","family":"Salmona","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Pharmacology, Mario Negri Institute for Pharmacological Research, Milano 20156, Italy"}]},{"given":"Marco","family":"Gobbi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Pharmacology, Mario Negri Institute for Pharmacological Research, Milano 20156, Italy"}]}],"member":"1968","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1056\/NEJMra0912273","article-title":"Nanomedicine","volume":"363","author":"Kim","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/anie.200802585","article-title":"Nanomedicine\u2014challenge and perspectives","volume":"48","author":"Riehemann","year":"2009","journal-title":"Angew. Chem. Int. Ed. Engl"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat. Rev. Drug Discov"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0163-7827(03)00033-X","article-title":"Stealth liposomes and long circulating nanoparticles: Critical issues in pharmacokinetics, opsonization and protein-binding properties","volume":"42","author":"Moghimi","year":"2003","journal-title":"Prog. Lipid Res"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"14265","DOI":"10.1073\/pnas.0805135105","article-title":"Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts","volume":"105","author":"Lundqvist","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nnano.2010.267","article-title":"Nanobiotechnology: Nanoparticle coronas take shape","volume":"6","author":"Monopoli","year":"2011","journal-title":"Nat. Nanotechnol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1021\/ja107583h","article-title":"Physical-chemical aspects of protein corona: Relevance to in vitro and in vivo biological impacts of nanoparticles","volume":"133","author":"Monopoli","year":"2011","journal-title":"J. Am. Chem. Soc"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1021\/nn201950e","article-title":"Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: A comprehensive quantitative proteomic analysis","volume":"5","author":"Tenzer","year":"2011","journal-title":"ACS Nano"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.chembiol.2006.11.015","article-title":"The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform","volume":"14","author":"Hong","year":"2007","journal-title":"Chem. Biol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P","article-title":"Design of folic acid-conjugated nanoparticles for drug targeting","volume":"89","author":"Stella","year":"2000","journal-title":"J. Pharm. Sci"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jhep.2011.05.039","article-title":"Nanotechnology for therapy and imaging of liver diseases","volume":"55","author":"Reddy","year":"2011","journal-title":"J. Hepatol"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.1074\/jbc.M109.085605","article-title":"Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: An integrated strategy for the development of new antiangiogenic compounds","volume":"285","author":"Colombo","year":"2010","journal-title":"J. Biol. Chem"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2006.10.040","article-title":"Higher-throughput, label-free, real-time molecular interaction analysis","volume":"361","author":"Rich","year":"2007","journal-title":"Anal. Biochem"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1074\/jbc.M506164200","article-title":"Gerstmann-straussler-scheinker disease amyloid protein polymerizes according to the \u201cDock-and-lock\u201d Model","volume":"281","author":"Gobbi","year":"2006","journal-title":"J. Biol. Chem"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ana.21740","article-title":"Recombinant c1 inhibitor in brain ischemic injury","volume":"66","author":"Gesuete","year":"2009","journal-title":"Ann. Neurol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0958-1669(97)80157-7","article-title":"Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors","volume":"8","author":"Myszka","year":"1997","journal-title":"Curr. Opin. Biotechnol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ab.2006.08.005","article-title":"Exploring \u201cOne-shot\u201d Kinetics and small molecule analysis using the proteon xpr36 array biosensor","volume":"358","author":"Bravman","year":"2006","journal-title":"Anal. Biochem"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1016\/j.biomaterials.2010.04.044","article-title":"Lipid-based nanoparticles with high binding affinity for amyloid-beta1\u201342 peptide","volume":"31","author":"Gobbi","year":"2010","journal-title":"Biomaterials"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.bios.2010.10.038","article-title":"Use of surface plasmon resonance to study the elongation kinetics and the binding properties of the highly amyloidogenic abeta(1\u201342) peptide, synthesized by depsi-peptide technique","volume":"26","author":"Stravalaci","year":"2010","journal-title":"Biosens Bioelectron"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Dossi, M., Ferrari, R., Dragoni, L., Martignoni, C., Gaetani, P., D\u2019Incalci, M., Morbidelli, M., and Moscatelli, D. (2012). Synthesis of fluorescent pmma-based nanoparticles. Macromol. Mater. Eng.","DOI":"10.1002\/mame.201200122"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1021\/bc900438a","article-title":"Binding affinity and kinetic analysis of targeted small molecule-modified nanoparticles","volume":"21","author":"Tassa","year":"2010","journal-title":"Bioconjug. Chem"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/abio.1999.4389","article-title":"A vesicle capture sensor chip for kinetic analysis of interactions with membrane-bound receptors","volume":"277","author":"Cooper","year":"2000","journal-title":"Anal. Biochem"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.chemphyslip.2006.02.010","article-title":"Surface plasmon resonance in protein-membrane interactions","volume":"141","author":"Besenicar","year":"2006","journal-title":"Chem. Phys. Lipids"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/abio.1999.4469","article-title":"Characterization of the surfaces generated by liposome binding to the modified dextran matrix of a surface plasmon resonance sensor chip","volume":"280","author":"Erb","year":"2000","journal-title":"Anal. Biochem"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ab.2005.06.013","article-title":"Properties of nonfused liposomes immobilized on an l1 biacore chip and their permeabilization by a eukaryotic pore-forming toxin","volume":"344","author":"Anderluh","year":"2005","journal-title":"Anal. Biochem"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0003-2697(02)00278-6","article-title":"Surface plasmon resonance characterization of drug\/liposome interactions","volume":"310","author":"Baird","year":"2002","journal-title":"Anal. Biochem"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1005576831968","article-title":"A quantitative approach to membrane binding of human ubiquitous mitochondrial creatine kinase using surface plasmon resonance","volume":"32","author":"Schlattner","year":"2000","journal-title":"J. Bioenerg. Biomembr"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1074\/jbc.272.9.5533","article-title":"Quantitative analysis of bacterial toxin affinity and specificity for glycolipid receptors by surface plasmon resonance","volume":"272","author":"MacKenzie","year":"1997","journal-title":"J. Biol. Chem"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/cphc.200301061","article-title":"DNA-based formation of a supported, three-dimensional lipid vesicle matrix probed by qcm-d and spr","volume":"5","author":"Graneli","year":"2004","journal-title":"Chemphyschem"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1073\/pnas.0608582104","article-title":"Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles","volume":"104","author":"Cedervall","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"15437","DOI":"10.1021\/ja8041806","article-title":"Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles","volume":"130","author":"Lynch","year":"2008","journal-title":"J. Am. Chem. Soc"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.biomaterials.2010.10.027","article-title":"Curcumin-decorated nanoliposomes with very high affinity for amyloid-beta1\u201342 peptide","volume":"32","author":"Mourtas","year":"2011","journal-title":"Biomaterials"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1016\/j.biomaterials.2011.04.020","article-title":"The binding affinity of anti-abeta1\u201342 mab-decorated nanoliposomes to abeta1-42 peptides in vitro and to amyloid deposits in post-mortem tissue","volume":"32","author":"Canovi","year":"2011","journal-title":"Biomaterials"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1161\/CIRCULATIONAHA.112.103051","article-title":"Targeting mannose binding lectin confers long lasting protection with a surprisingly wide therapeutic window in cerebral ischemia","volume":"126","author":"Orsini","year":"2012","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nano.2008.08.001","article-title":"Interaction of colloidal gold nanoparticles with human blood: Effects on particle size and analysis of plasma protein binding profiles","volume":"5","author":"Dobrovolskaia","year":"2009","journal-title":"Nanomedicine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1021\/ja2084338","article-title":"Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake","volume":"134","author":"Walkey","year":"2012","journal-title":"J. Am. Chem. Soc"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nmat2442","article-title":"Understanding biophysicochemical interactions at the nano-bio interface","volume":"8","author":"Nel","year":"2009","journal-title":"Nat. Mater"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1021\/nn202458g","article-title":"The evolution of the protein corona around nanoparticles: A test study","volume":"5","author":"Lundqvist","year":"2011","journal-title":"ACS Nano"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1021\/nn901372t","article-title":"Time evolution of the nanoparticle protein corona","volume":"4","author":"Casals","year":"2010","journal-title":"ACS Nano"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e10949","DOI":"10.1371\/journal.pone.0010949","article-title":"Modeling the time evolution of the nanoparticle-protein corona in a body fluid","volume":"5","author":"Lundqvist","year":"2010","journal-title":"PLoS One"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1002\/anie.200700465","article-title":"Detailed identification of plasma proteins adsorbed on copolymer nanoparticles","volume":"46","author":"Cedervall","year":"2007","journal-title":"Angew. Chem. Int. Ed. Engl"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s00018-009-0053-z","article-title":"Nanocarriers\u2019 entry into the cell: Relevance to drug delivery","volume":"66","author":"Hillaireau","year":"2009","journal-title":"Cell. Mol. Life Sci"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: Theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol. Rev"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jconrel.2004.07.028","article-title":"Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: Implications for rational design of nanoparticles","volume":"100","author":"Ogawara","year":"2004","journal-title":"J. Control. Release"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10611860290031877","article-title":"Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier","volume":"10","author":"Kreuter","year":"2002","journal-title":"J. Drug Target"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1124\/jpet.105.097139","article-title":"Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain","volume":"317","author":"Michaelis","year":"2006","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2009.03.002","article-title":"Albumin nanoparticles targeted with apo e enter the cns by transcytosis and are delivered to neurones","volume":"137","author":"Zensi","year":"2009","journal-title":"J. Control. Release"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e32568","DOI":"10.1371\/journal.pone.0032568","article-title":"Uptake mechanism of apoe-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model","volume":"7","author":"Wagner","year":"2012","journal-title":"PLoS One"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jbiotec.2011.06.037","article-title":"Functionalization with apoe-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide","volume":"156","author":"Re","year":"2010","journal-title":"J. Biotechnol"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.nano.2011.05.004","article-title":"Functionalization of liposomes with apoe-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model","volume":"7","author":"Re","year":"2011","journal-title":"Nanomedicine"}],"container-title":["Sensors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8220\/12\/12\/16420\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:53:52Z","timestamp":1760219632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8220\/12\/12\/16420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,27]]},"references-count":51,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12]]}},"alternative-id":["s121216420"],"URL":"https:\/\/doi.org\/10.3390\/s121216420","relation":{},"ISSN":["1424-8220"],"issn-type":[{"type":"electronic","value":"1424-8220"}],"subject":[],"published":{"date-parts":[[2012,11,27]]}}}